Consolidated Research: 2018 Summary Expectations for Insight Enterprises, Amphastar Pharmaceuticals, EMC Insurance Group, Prothena Corporation plc, Mizuho Financial Group, and Baytex Energy — Fundamental Analysis, Key Performance Indications


NEW YORK, April 12, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Insight Enterprises, Inc. (NASDAQ:NSIT), Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH), EMC Insurance Group Inc. (NASDAQ:EMCI), Prothena Corporation plc (NASDAQ:PRTA), Mizuho Financial Group, Inc. (NYSE:MFG), and Baytex Energy Corp (NYSE:BTE), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

NSIT DOWNLOAD: http://Fundamental-Markets.com/register/?so=NSIT
AMPH DOWNLOAD: http://Fundamental-Markets.com/register/?so=AMPH
EMCI DOWNLOAD: http://Fundamental-Markets.com/register/?so=EMCI
PRTA DOWNLOAD: http://Fundamental-Markets.com/register/?so=PRTA
MFG DOWNLOAD: http://Fundamental-Markets.com/register/?so=MFG
BTE DOWNLOAD: http://Fundamental-Markets.com/register/?so=BTE

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Insight Enterprises, Inc. (NASDAQ:NSIT), Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH), EMC Insurance Group Inc. (NASDAQ:EMCI), Prothena Corporation plc (NASDAQ:PRTA), Mizuho Financial Group, Inc. (NYSE:MFG), and Baytex Energy Corp (NYSE:BTE) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed April 10th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

INSIGHT ENTERPRISES, INC. (NSIT) REPORT OVERVIEW

Insight Enterprises' Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Insight Enterprises reported revenue of $1,784.08MM vs $1,467.58MM (up 21.57%) and basic earnings per share $0.39 vs $0.59 (down 33.90%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Insight Enterprises reported revenue of $6,703.62MM vs $5,485.52MM (up 22.21%) and basic earnings per share $2.54 vs $2.35 (up 8.09%). Insight Enterprises is expected to report earnings on May 2nd, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.56. The estimated EPS forecast for the next fiscal year is $4.27 and is expected to report on February 13th, 2019.

To read the full Insight Enterprises, Inc. (NSIT) report, download it here: http://Fundamental-Markets.com/register/?so=NSIT

-----------------------------------------

AMPHASTAR PHARMACEUTICALS, INC. (AMPH) REPORT OVERVIEW

Amphastar Pharmaceuticals' Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Amphastar Pharmaceuticals reported revenue of $60.40MM vs $63.54MM (down 4.94%) and basic earnings per share $0.04 vs -$0.07. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Amphastar Pharmaceuticals reported revenue of $240.18MM vs $255.17MM (down 5.87%) and basic earnings per share $0.10 vs $0.23 (down 56.52%). Amphastar Pharmaceuticals is expected to report earnings on May 14th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.03. The estimated EPS forecast for the next fiscal year is $1.37 and is expected to report on March 11th, 2019.

To read the full Amphastar Pharmaceuticals, Inc. (AMPH) report, download it here: http://Fundamental-Markets.com/register/?so=AMPH

-----------------------------------------

EMC INSURANCE GROUP INC. (EMCI) REPORT OVERVIEW

EMC Insurance Group's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, EMC Insurance Group reported revenue of $174.32MM vs $168.40MM (up 3.52%) and basic earnings per share $1.23 vs $1.01 (up 21.78%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, EMC Insurance Group reported revenue of $658.85MM vs $644.98MM (up 2.15%) and basic earnings per share $1.84 vs $2.20 (down 16.36%). EMC Insurance Group is expected to report earnings on May 4th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.34.

To read the full EMC Insurance Group Inc. (EMCI) report, download it here: http://Fundamental-Markets.com/register/?so=EMCI

-----------------------------------------

PROTHENA CORPORATION PLC (PRTA) REPORT OVERVIEW

Prothena Corporation plc's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Prothena Corporation plc reported revenue of $0.23MM vs $0.17MM (up 33.92%) and basic earnings per share -$1.25 vs -$1.41. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Prothena Corporation plc reported revenue of $27.52MM vs $1.06MM (up 2,508.44%) and basic earnings per share -$4.07 vs -$4.66. Prothena Corporation plc is expected to report earnings on May 8th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.99. The estimated EPS forecast for the next fiscal year is -$4.10 and is expected to report on February 13th, 2019.

To read the full Prothena Corporation plc (PRTA) report, download it here: http://Fundamental-Markets.com/register/?so=PRTA

-----------------------------------------

MIZUHO FINANCIAL GROUP, INC. (MFG) REPORT OVERVIEW

Mizuho Financial Group's Recent Financial Performance

For the twelve months ended March 31st, 2017 vs March 31st, 2016, Mizuho Financial Group reported interest income of $13,443.66MM vs $11,837.92MM (up 13.56%) and basic earnings per share $0.44 vs $0.45 (down 1.61%). Mizuho Financial Group is expected to report earnings on May 21st, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.07. The estimated EPS forecast for the next fiscal year is $0.42 and is expected to report on May 21st, 2018.

To read the full Mizuho Financial Group, Inc. (MFG) report, download it here: http://Fundamental-Markets.com/register/?so=MFG

-----------------------------------------

BAYTEX ENERGY CORP (BTE) REPORT OVERVIEW

Baytex Energy's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Baytex Energy reported revenue of $183.37MM vs $132.17MM (up 38.74%) and basic earnings per share $0.25 vs -$1.12. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Baytex Energy reported revenue of $655.41MM vs $454.61MM (up 44.17%) and basic earnings per share $0.29 vs -$1.73. Baytex Energy is expected to report earnings on May 3rd, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.04. The estimated EPS forecast for the next fiscal year is -$0.17 and is expected to report on March 5th, 2019.

To read the full Baytex Energy Corp (BTE) report, download it here: http://Fundamental-Markets.com/register/?so=BTE

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.